cousineg
Messages : 1058
Enregistré le : lun. août 14, 2006 4:36 am
Localisation : Montréal (Ar. Saint-Laurent)

Sprycel ( dasatinib) – Approbation totale par la FDA

sam. juin 06, 2009 1:31 am

FDA Grants Full Approval for Sprycel (dasatinib) for the Treatment of Adults with Chronic Myeloid Leukemia Who Are Resistant or Intolerant to Prior Therapies Including Gleevec
Two-Year Follow-Up Data Includes 80 Percent Progression-Free Survival Rate in Gleevec-Resistant or Intolerant Patients with Chronic Phase CML
–Pharmalive.com - May 26, 2009

Voir http://www.pharmalive.com/news/index.cf ... 3&search=1

FDA Okays Sprycel for CML Resistant or Intolerant to Gleevec
By Todd Neale, Staff Writer, MedPage Today
Published: May 27, 2009

Voir http://www.medpagetoday.com/HematologyO ... kemia/3651

FDA Grants Full Approval for SPRYCEL(R) (dasatinib) for the Treatment of Adults with Chronic...
Forbes.com, 05.26.09

Voir http://www.forbes.com/feeds/businesswir ... 99716.html

FDA grants full approval for Sprycel (dasatinib) for chronic myeloid leukemia
The Medical News – New-York - 27. mai 2009

Voir http://www.news-medical.net/news/2009/0 ... kemia.aspx

FDA Approvals: Sprycel and Microcyn
Yael Waknine, Medscape.com, June 4, 2009

Voir http://www.medscape.com/viewarticle/703811?src=rss <

Sprycel receives full approval for chronic myeloid leukemia
MPR Monthly Prescribing reference, May 27, 2009

Voir http://www.empr.com/Sprycel-receives-fu ... le/137526/


FDA Grants Full Approval for SPRYCEL(R) (dasatinib) for the Treatment of Adults with Chronic Myeloid Leukemia Who Are Resistant or Intolerant to Prior Therapies Including Gleevec(R)* Two-Year Follow-Up Data Includes 80 Percent Progression-Free Survival Rate in Gleevec-Resistant or Intolerant Patients with Chronic Phase CML , CNBC, NEW YORK, May 26, 2009
Voir http://www.cnbc.com/id/30946376/site/14081545


FDA Grants Full Approval For SPRYCEL For The Treatment Of Adults With Chronic Myeloid Leukemia Medical News Today, 27 May 2009
Voir http://www.medicalnewstoday.com/articles/151579.php

Articles antérieurs


FDA Approves SPRYCEL™ (dasatinib) With Two Indications
, leukemia-web.org, PRINCETON, NJ (June 28, 2006)

http://www.leukemia-web.org/aml-leukemi ... s-0149.htm

FDA grants accelerated approval for Sprycel (dasatinib) , Drug News - Jun 30, 2006
Voir http://www.empr.com/Sprycel-receives-fu ... le/137526/

La FDA approuve le dasatinib pour la LMC, Revue Source, Septembre 2006
Voir http://cmlsource.ca/fda_approves_dasati ... php?lang=2

Retourner vers « Leucémie Myéloïde Chronique »

Connexion  •  S’enregistrer